846 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
3. The need for increased pragmatism in cardiovascular clinical trials
4. Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
5. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
6. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
7. Nano-based remediation strategies for micro and nanoplastic pollution
8. Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
9. Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation
10. Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results
11. Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials
12. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
13. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
14. In Silico modeling and exploration of new acceptor molecules with enhanced power conversion efficiency for high-performance organic solar cell applications
15. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
16. Cardiovascular implications of COVID-19 versus influenza infection: a review.
17. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
18. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
19. Medication-Attributable Adverse Events in Heart Failure Trials
20. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
21. Trends in prevalence of comorbidities in heart failure clinical trials
22. Combustion and emission characterization of upgraded biomass fast pyrolysis oil in a swirl burner
23. CuO-decorated MOF derived ZnO polyhedral nanostructures for exceptional H2S gas detection
24. The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
25. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States
26. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials
27. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
28. A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials: Trial Flow and Results
29. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
30. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
31. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
32. Mental health disorders and readmissions following acute myocardial infarction in the United States
33. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
34. The effect of preheating of a viscous and non-Newtonian bioliquid on its internally mixed twin-fluid atomization
35. Role of anti‐obesity drugs in heart failure regardless of ejection fraction.
36. Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
37. High electron mobility due to extra π-conjugation in the end-capped units of non-fullerene acceptor molecules: a DFT/TD-DFT-based prediction
38. Theoretical designing of selenium heterocyclic non-fullerene acceptors with enhanced power conversion efficiency for organic solar cells: a DFT/TD-DFT-based prediction and understanding
39. Association of diabetes‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study
40. Efficient electrocatalytic oxygen evolution by nano NiO-In 2 O 3 electrode materials
41. The effect of sodium–glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta‐analysis
42. Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?
43. Kidney involvement in transthyretin cardiac amyloidosis – Role of urinary albumin to creatinine ratio and need for further evidence generation
44. Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey
45. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
46. Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality
47. Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review
48. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
49. Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement
50. Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.